Lisata Therapeutics (DE:8NE)

Lisata Therapeutics (8NE) Cash flow


Lisata Therapeutics Cash Flow

DE:8NE's free cash flow for Q3 2023 was $-3.58M. For the 2023 fiscal year, DE:8NE's free cash flow was decreased by $850.00K and operating cash flow was $-3.58M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -22.43M$ -21.17M$ -22.25M$ -8.82M$ -18.88M$ -19.99M
Investing Cash Flow
$ 22.92M$ 28.91M$ -54.90M$ -7.28M$ 21.43M$ -4.71M
Financing Cash Flow
$ 375.00K$ -224.00K$ 85.28M$ 18.58M$ 1.18M$ 824.00K
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 116.38M$ 32.15M$ 24.65M$ 16.51M$ 14.03M$ 10.30M
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
---$ 0.00$ 0.00$ 5.00K
Issuance Of Capital Stock
$ 311.00K$ 43.00K$ 85.50M$ 18.73M$ 1.31M$ 1.03M
Issuance Of Debt
-----$ 0.00
Repayment Of Debt
----$ 0.00$ -159.00K
Free Cash Flow
$ -22.46M$ -21.45M$ -22.30M$ -8.84M$ -18.88M$ -20.12M
Domestic Sales
Foreign Sales
Currency in USD

Lisata Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis